Related references
Note: Only part of the references are listed.Interferon lambda-3 polymorphism and response to pegylated interferon in patients with hepatitis D
Zaigham Abbas et al.
ANTIVIRAL THERAPY (2015)
Efficacy of prolonged tenofovir therapy on hepatitis delta in HIV-infected patients
Vincent Soriano et al.
AIDS (2014)
Use of FDA approved therapeutics with hNTCP metabolic inhibitory properties to impair the HDV lifecycle
Matthieu Blanchet et al.
ANTIVIRAL RESEARCH (2014)
Treatment of chronic hepatitis D patients with pegylated interferon: a real-world experience
Zaigham Abbas et al.
ANTIVIRAL THERAPY (2014)
Strategies to Inhibit Entry of HBV and HDV Into Hepatocytes
Stephan Urban et al.
GASTROENTEROLOGY (2014)
Hepatitis B and D Viruses Exploit Sodium Taurocholate Co-transporting Polypeptide for Species-Specific Entry into Hepatocytes
Yi Ni et al.
GASTROENTEROLOGY (2014)
Late HDV RNA Relapse After Peginterferon Alpha-Based Therapy of Chronic Hepatitis Delta
Benjamin Heidrich et al.
HEPATOLOGY (2014)
Understanding Early Serum Hepatitis D Virus and Hepatitis B Surface Antigen Kinetics During Pegylated Interferon-alpha Therapy Via Mathematical Modeling
Jeremie Guedj et al.
HEPATOLOGY (2014)
Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor
Shirin Nkongolo et al.
JOURNAL OF HEPATOLOGY (2014)
Structure-Activity Relationship for FDA Approved Drugs As Inhibitors of the Human Sodium Taurocholate Cotransporting Polypeptide (NTCP)
Zhongqi Dong et al.
MOLECULAR PHARMACEUTICS (2013)
Life cycle and pathogenesis of hepatitis D virus: A review
Zaigham Abbas et al.
WORLD JOURNAL OF HEPATOLOGY (2013)
Treatment of Chronic Delta Hepatitis
Cihan Yurdaydin
SEMINARS IN LIVER DISEASE (2012)
Viroids and Hepatitis Delta Virus
Ricardo Flores et al.
SEMINARS IN LIVER DISEASE (2012)
Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus
Huan Yan et al.
ELIFE (2012)
Hepatitis D virus: an update
Stephanie Pascarella et al.
LIVER INTERNATIONAL (2011)
Hepatitis D revival
Heiner Wedemeyer
LIVER INTERNATIONAL (2011)
Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta
Heiner Wedemeyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interferon alpha for chronic hepatitis D
Zaigham Abbas et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2011)
Hepatitis D: Scenario in the Asia-Pacific region
Zaigham Abbas et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Large hepatitis delta antigen modulates transforming growth factor-beta signaling cascades: Implication of hepatitis delta virus-induced liver fibrosis
Soo-Ho Choi et al.
GASTROENTEROLOGY (2007)
Treatment of chronic hepatitis delta with pegylated interferon-α2b
Andreas Erhardt et al.
LIVER INTERNATIONAL (2006)
Antisense oligonucleotides: From design to therapeutic application
JHP Chan et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2006)
A prenylation inhibitor prevents production of infectious hepatitis delta virus particles
BB Bordier et al.
JOURNAL OF VIROLOGY (2002)
Share Paper
